DANIEL M GELFMAN MD
Prescription History 1457325821
Internal Medicine - Cardiovascular Disease in Indianapolis, IN

Active since February 14, 2006PECOS Enrolled
72.86/100
CMS Quality Rating
8333 NAAB RD STE 400, INDIANAPOLIS, IN 46260(317) 338-6666(317) 338-6066 Get Directions

NPPES record last updated: September 30, 2014. Verified against the NPPES registry weekly; last sync: July 26, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DANIEL M GELFMAN MD, an active Cardiovascular Disease specialist practicing in Indianapolis, IN. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 29 documented patient claims. Among these therapy options, the most frequently utilized medication is Metoprolol Succinate, which accounts for 29 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
29
Total Claims
79
30-Day Fills
Metoprolol Succinate
Most Prescribed · 29 claims
View details
1 medication · 2023 Medicare Part D
Medicare Part D medications prescribed by DANIEL M GELFMAN MD in 2023, with prescription volumes, average cost per fill, and IN state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other IN PrescribersVs. IN Avg
Metoprolol Succinate29$30.54 Less than typical

About Metoprolol Succinate: This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Show more ▾

Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart. A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

In 2023, this provider wrote 29 Medicare prescriptions for Metoprolol Succinate, about a quarter of the volume of the typical Indiana prescriber of this medication (115). Medicare paid an average of $30.54 per fill, versus $19.91 statewide.

How often this provider prescribes it

This provider
29
IN average
115.0

This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$30.54
IN average
$19.91

Gross Part D cost per fill; not the patient's out-of-pocket price.

79
30-Day Fills
standardized to 30-day supplies
2,370
Days of Medication
total across all patients in 2023
No medications match the current filters.
More than typical Typical Less than typical= prescription volume vs the average IN prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the IN average cost per fill.

About this data. The prescription history for DANIEL M GELFMAN MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Cardiovascular Disease prescribing approach at this Indianapolis, IN practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.